Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Outdoor Guide
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
Readersâ Choice
Auction
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IONS
Recent news which mentions IONS
< Previous
1
2
3
4
Next >
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
May 04, 2023
Tickers
ABSI
BLDR
BLKB
CERE
Tags
UPWK
BLDR
Market News
From
Benzinga
Recap: Ionis Pharmaceuticals Q1 Earnings
May 03, 2023
Tickers
IONS
Tags
BZI/Recaps
Earnings
Market News
From
Benzinga
Ionis Pharmaceuticals's Earnings Outlook
May 02, 2023
Tickers
IONS
Tags
BZI/EP
Benzinga
Earnings
From
Benzinga
Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
April 26, 2023
Tickers
BIIB
IONS
Tags
General
Benzinga
IONS
From
Benzinga
FDA grants accelerated approval to Biogen treatment for rare form of ALS
April 25, 2023
Tickers
BIIB
IONS
Tags
BIIB
IONS
From
MarketWatch
What's Going On With Biogen Stock Tuesday?
April 25, 2023
Tickers
BIIB
IONS
Tags
Movers
Market News
Benzinga
From
Benzinga
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
April 25, 2023
Tickers
BIIB
IONS
Tags
Guidance
Biotech
BIIB
From
Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
April 24, 2023
Tickers
ACRS
AMRS
IONS
Tags
Market News
NASDAQ:AMRS,NASDAQ:ACRS,NASDAQ:IONS
Stocks to Sell
From
InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
April 24, 2023
Tickers
AZN
AZNCF
IONS
Tags
Biotech
AZNCF
AZN
From
Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
April 19, 2023
Tickers
AZN
IONS
Tags
AZN
Market News
IONS
From
Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
April 12, 2023
Tickers
ALNY
ARWR
IONS
MRNA
Tags
Expert Ideas
Market News
ALNY
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
April 11, 2023
Tickers
IONS
Tags
BZI/AAR
Market News
IONS
From
Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
March 27, 2023
Tickers
AZN
AZNCF
BXRX
IONS
Tags
General
Benzinga
AZN
From
Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
Tickers
BIIB
IONS
Tags
FDA
BIIB
Biotech
From
Benzinga
Analyst Ratings for Ionis Pharmaceuticals
March 21, 2023
Tickers
IONS
Tags
BZI/AAR
IONS
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
March 21, 2023
Tickers
ADC
AIZ
ALLO
ALNY
Tags
ALLO
OSH
IONS
From
Benzinga
Wall Street predicts approval for another ALS drug
March 21, 2023
Tickers
AMLX
BIIB
IONS
Tags
BIIB
JP:4523
IONS
From
MarketWatch
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
Tickers
BIIB
IONS
Tags
General
Benzinga
Markets
From
Benzinga
Ionis Pharmaceuticals's Earnings Outlook
February 21, 2023
Tickers
IONS
Tags
Benzinga
BZI/EP
Earnings
From
Benzinga
Analyst Says Ionis' Additional Hereditary Angioedema Study Data Supports 'Highly Competitive Profile'
February 21, 2023
Tickers
IONS
Tags
News
Analyst Color
Analyst Ratings
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
January 19, 2023
Tickers
IONS
Tags
BZI/AAR
Analyst Ratings
Benzinga
From
Benzinga
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
January 11, 2023
Tickers
ARKG
EXAS
IONS
PACB
Tags
active biotech ETF
PACB
EXAS
From
ETF Trends
The Latest Analyst Ratings for Ionis Pharmaceuticals
December 21, 2022
Tickers
IONS
Tags
Analyst Ratings
Benzinga
IONS
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
December 21, 2022
Tickers
ADPT
AIMC
AMV
APPN
Tags
BZI/Ratings
USB
INMD
From
Benzinga
Ionis Pharmaceuticals Earnings Perspective: Return On Capital Employed
December 13, 2022
Tickers
IONS
Tags
BZI/ROCE
Market News
IONS
From
Benzinga
Gene Deal Adds New Dimension to Biotech ETF SBIO
November 16, 2022
Tickers
ALPS
IONS
SBIO
Tags
SBIO
IONS
ALPS
From
ETF Trends
4 Analysts Have This to Say About Ionis Pharmaceuticals
November 10, 2022
Tickers
IONS
Tags
BZI/AAR
Analyst Ratings
Benzinga
From
Benzinga
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
November 10, 2022
Tickers
HCAT
IONS
PSX
RSKD
Tags
RSKD
News
Small Cap
From
Benzinga
Ionis Regains Rights To Thrombosis Candidate From Bayer
November 04, 2022
Tickers
BAYRY
BAYZF
IONS
Tags
Benzinga
General
IONS
From
Benzinga
3 Biotech Stocks to Sell in October
September 29, 2022
Tickers
GILD
GLPG
ILMN
IONS
Tags
NASDAQ:ILMN,NASDAQ:GLPG,NASDAQ:IONS,NASDAQ:GILD
IONS
GILD
From
InvestorPlace
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.